WDNA

Fund Description
The WisdomTree BioRevolution Fund ( Fund ) seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index ( Index ). The Fund employs a passive management or indexing investment approach designed to track the performance of the Index. The Fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the Index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The Index is designed to provide exposure to equity securities of exchange-listed companies globally that will be significantly transformed byadvancements in genetics and biotechnology. The Index constituents are determined by an Index committee that looks at companies focusing on: the application of genetic technologies to prevent and treat disease; the applications of human genetic technologies to new classes of consumer products personalized for each individual; the transformation of agriculture, aquaculture, and food production, creating healthier and more sustainable models for feeding the growing global population; biological re-engineering used to produce an increasing percentage of the physical inputs needed for manufacturing; and/or DNA as a storage solution (collectively, BioRevolution Activities ).
Fund Profile
Fund Name WisdomTree BioRevolution Fund
Fund Exchange Ticker WDNA
Fund Sponsor Wisdom Tree
Fund ISIN US97717Y6187
Net Expense Ratio 0.45 %
Fund Inception Date 3 June 2021
Fund Legal Structure ETF (Open end fund)
Exchange BATS
Listing Country Code US
Fund Investment Objective
ETF Type Specific Global or ExUS Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name WisdomTree BioRevolution Index
Index Provider Wisdom Tree
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent Not Applicable
Key Statistics
Return As of Date 22 September 2022
Asset Under Management 4.62 Million (USD)
1 Month Total Return -11.16 %
Year To Date Return -27.60 %
1 Year Total Return -33.08 %
3 Year Annualized Total Return
NAV 17.0941
Share Outstanding 270,000
Top 10 Holdings (23 September 2022)
Constituent Name Constituent Ticker Constituent Type Weighting
ELI LILLY & CO LLY EQUI 0.0298217410
ASTRAZENECA PLC-SPONS ADR AZN EQUI 0.0260329130
VERTEX PHARMACEUTICALS INC VRTX EQUI 0.0239986489
ARCHER-DANIELS-MIDLAND CO ADM EQUI 0.0210647417
REGENERON PHARMACEUTICALS REGN EQUI 0.0208650335
PFIZER INC PFE EQUI 0.0203897078
CORTEVA INC CTVA EQUI 0.0200904592
THERMO FISHER SCIENTIFIC INC TMO EQUI 0.0196226892
MERCK & CO. INC. MRK EQUI 0.0191761656
SAREPTA THERAPEUTICS INC SRPT EQUI 0.0191593543